Loading page…
TSH Biopharm Co Ltd 2024 Annual Report with Sustainability Disclosures
Company: TSH Biopharm Co Ltd
Sector: Wholesale & retail
Country: Taiwan
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 138
The report records consolidated net operating revenue of NT$1,115,716 thousand in 2024, up 37.59% from 2023. It highlights new product authorizations, including Amtrel in Malaysia and Tyrvaya in Taiwan, alongside developments in cancer testing. The company also reports acquiring two subsidiaries during 2024. Its climate disclosure sets a goal to reduce total energy consumption by 1% by 2029, based on 2024.
Indicators available in this report: